| |
| |
|
| Insider
Information: |
Watanabe Todd Franklin |
| Relationship: |
See Remarks, Director |
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
860,750 |
|
|
Indirect Shares
|
231,140 |
|
|
| Direct
Value |
$7,850,040 |
|
|
|
Indirect Value
|
$2,107,997 |
|
|
| Total
Shares |
1,091,890 |
|
|
| Total
Value |
$9,958,037 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcutis Biotherapeutics, Inc. |
ARQT |
See Remarks, Director |
2024-05-02 |
860,750 |
2024-05-02 |
231,140 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQT |
Arcutis Biotherapeutics, ... |
Director |
– • – |
2020-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
378,483 |
|
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Director |
– • – |
2020-01-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
160,656 |
|
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2020-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
99,964 |
478,447 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2020-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
49,981 |
49,981 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
29,000 |
507,447 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
598,916 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
7,377 |
57,358 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
70,900 |
663,526 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2022-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
268,964 |
382,907 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,126 |
502,019 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2023-12-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
13,126 |
24,413 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2024-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
627,019 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
See Remarks |
• • – |
2024-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
264,882 |
891,901 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2020-03-13 |
4 |
OE |
$1.68 |
$99,964 |
D/D |
59,481 |
566,928 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2020-09-29 |
4 |
OE |
$1.68 |
$5,042 |
D/D |
3,000 |
569,928 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-01-05 |
4/A |
OE |
$1.68 |
$16,806 |
D/D |
10,000 |
578,323 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-02-05 |
4 |
OE |
$1.68 |
$16,806 |
D/D |
10,000 |
578,323 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-05-05 |
4 |
OE |
$1.68 |
$2,701 |
D/D |
1,607 |
595,523 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-05-07 |
4 |
OE |
$1.68 |
$1,260 |
D/D |
750 |
594,523 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-06-07 |
4 |
OE |
$1.68 |
$2,941 |
D/D |
1,750 |
596,529 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-07-06 |
4 |
OE |
$1.68 |
$2,941 |
D/D |
1,750 |
596,529 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-08-05 |
4 |
OE |
$1.68 |
$1,681 |
D/D |
1,000 |
595,779 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-09-07 |
4 |
OE |
$1.68 |
$1,681 |
D/D |
1,000 |
595,779 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-10-01 |
4 |
OE |
$1.68 |
$2,521 |
D/D |
1,500 |
596,279 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
President and CEO |
• • – |
2021-10-05 |
4 |
OE |
$1.68 |
$4,202 |
D/D |
2,500 |
597,279 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
